These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25531908)

  • 21. H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17.
    Huang Z; Lei W; Hu HB; Zhang H; Zhu Y
    J Cell Physiol; 2018 Oct; 233(10):6768-6776. PubMed ID: 29693721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
    Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G
    Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH; Zhang CL; Dong FS; Zhang YM
    J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer.
    Wang L; Kong W; Liu B; Zhang X
    Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer.
    Shen H; Shen J; Wang L; Shi Z; Wang M; Jiang BH; Shu Y
    Biomed Pharmacother; 2015 Feb; 69():301-5. PubMed ID: 25661374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.
    Ceppi P; Mudduluru G; Kumarswamy R; Rapa I; Scagliotti GV; Papotti M; Allgayer H
    Mol Cancer Res; 2010 Sep; 8(9):1207-16. PubMed ID: 20696752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
    Yan B; Zhang W; Mao XW; Jiang LY
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer.
    Zheng J; Wang F; Lu S; Wang X
    Exp Mol Pathol; 2016 Feb; 100(1):116-24. PubMed ID: 26683818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2.
    Wang P; Lv HY; Zhou DM; Zhang EN
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
    Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
    Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer.
    Li J; Li P; Chen T; Gao G; Chen X; Du Y; Zhang R; Yang R; Zhao W; Dun S; Gao F; Zhang G
    Tumour Biol; 2015 Feb; 36(2):685-92. PubMed ID: 25286764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
    Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
    FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-25 targets the modulator of apoptosis 1 gene in lung cancer.
    Wu T; Chen W; Kong D; Li X; Lu H; Liu S; Wang J; Du L; Kong Q; Huang X; Lu Z
    Carcinogenesis; 2015 Aug; 36(8):925-35. PubMed ID: 25998847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-429 induces tumorigenesis of human non-small cell lung cancer cells and targets multiple tumor suppressor genes.
    Lang Y; Xu S; Ma J; Wu J; Jin S; Cao S; Yu Y
    Biochem Biophys Res Commun; 2014 Jul; 450(1):154-9. PubMed ID: 24866238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.
    Li M; Zheng R; Yuan FL
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5987-5993. PubMed ID: 30280781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between the expression levels of miR-1 and PIK3CA in non-small-cell lung cancer and their relationship with clinical characteristics and prognosis.
    Zhao Q; Zhang B; Shao Y; Chen L; Wang X; Zhang Z; Shu Y; Guo R
    Future Oncol; 2014 Jan; 10(1):49-57. PubMed ID: 24328409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer.
    Li ZH; Zhang H; Yang ZG; Wen GQ; Cui YB; Shao GG
    J Int Med Res; 2013 Oct; 41(5):1437-44. PubMed ID: 24065453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abberent expression of oncogenic and tumor-suppressive microRNAs and their target genes in human adenocarcinoma alveolar basal epithelial cells.
    Tafsiri E; Darbouy M; Shadmehr MB; Cho WC; Karimipoor M
    J Cancer Res Ther; 2016; 12(1):395-400. PubMed ID: 27072269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.